Michael Seth Altman

Insider Reports History

Entity
Individual
Location
C/O Perceptive Advisors, 51 Astor Place, 10 Th Floor, New York, NY
Signature
/s/ Samuel M. Cohn, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Seth Altman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARYA Sciences Acquisition Corp V Chief Financial Officer, Director, 10%+ Owner Class A ordinary shares 499K $4.99M $10.00 Jul 15, 2021 By ARYA Sciences Holdings V
Perceptive Capital Solutions Corp Chief Business Officer, Director, 10%+ Owner Class A ordinary shares 286K $2.86M $10.00 Jun 13, 2024 By Perceptive Capital Solutions Holdings
Nautilus Biotechnology, Inc. Director Stock Option (Right to Buy) 45K Jun 14, 2024 Direct
Lyra Therapeutics, Inc. Director Stock Option 30K Jun 13, 2024 Direct
ARYA Sciences Acquisition Corp IV Chief Financial Officer, Director, 10%+ Owner Class A ordinary shares 0 Jul 31, 2024 By ARYA Sciences Holdings IV
ARYA Sciences Acquisition Corp IV Chief Financial Officer, Director, 10%+ Owner Class B ordinary shares 0 Jul 31, 2024 By ARYA Sciences Holdings IV

Insider Reports Filed by Michael Seth Altman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARYD ARYA Sciences Acquisition Corp IV Jul 31, 2024 3 $0 4 Jul 31, 2024 Chief Financial Officer, Director, 10%+ Owner
NAUT Nautilus Biotechnology, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
LYRA Lyra Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
PCSC Perceptive Capital Solutions Corp Jun 13, 2024 1 $2.86M 4 Jun 13, 2024 Chief Business Officer, Director, 10%+ Owner
PCSC Perceptive Capital Solutions Corp Jun 11, 2024 0 $0 3 Jun 11, 2024 Chief Business Officer, Director
LYRA Lyra Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
NAUT Nautilus Biotechnology, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
LYRA Lyra Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
NAUT Nautilus Biotechnology, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ARYE ARYA Sciences Acquisition Corp V Jul 15, 2021 1 $4.99M 4 Jul 15, 2021 Chief Financial Officer, Director, 10%+ Owner
ARYE ARYA Sciences Acquisition Corp V Jul 12, 2021 0 $0 3 Jul 12, 2021 Chief Financial Officer, Director, 10%+ Owner
NAUT Nautilus Biotechnology, Inc. Jun 9, 2021 5 $0 4 Jun 11, 2021 Director
LYRA Lyra Therapeutics, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director